Accumulating evidence suggests that M2-like TAMs play a central role in establishing an immunosuppressive TME that impairs anti-tumor immunity, particularly by inhibiting cytotoxic CD8+ T cell infiltration and function (35, 36). The gene discussed is CD8A; the disease is neoplasm.